Peru vs Uruguay: Previously treated cases tested for RR-/MDR-TB
Peru
95.0%
in 2024
Uruguay
95.0%
in 2024
Peru rank
66th
Uruguay rank
66th
Previously treated cases tested for RR-/MDR-TB over time
- Peru
- Uruguay
How they compare
Peru currently reports 95.0% against 95.0% in Uruguay, a difference of 0.0%.
The two have swapped places 4 times across 17 shared years of data; in 2006 it was Uruguay ahead.
Peru ranks 66th and Uruguay ranks 66th of 180 countries.
Across the 3 decades both report, Peru averaged higher in 2 and Uruguay in 1.
Head to head by decade
| Decade | Peru | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.3% | 71.0% | 47.7% | Uruguay |
| 2010s | 71.2% | 66.8% | 4.4% | Peru |
| 2020s | 82.4% | 77.2% | 5.2% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Peru or Uruguay?
- Peru, at 95.0% against 95.0% in Uruguay as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Peru and Uruguay?
- 0.0%, with Peru ahead.
- How many years of comparable data are there for Peru and Uruguay?
- 17 years are reported by both, from 2006 to 2024.
- How do Peru and Uruguay rank globally for previously treated cases tested for rr-/mdr-tb?
- Peru ranks 66th and Uruguay ranks 66th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.